Invesco Mortgage Capital (IVR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Agency residential mortgage-backed securities delivered modestly positive performance in 2024, supporting a consistent dividend and a 5.2% economic return despite market volatility and higher interest rates.
The capital structure was strengthened by issuing 13.2 million common shares and reducing preferred shares, lowering preferred stock from 37% to 24% of capital by year-end 2024.
The long-term outlook for Agency RMBS is favorable, with expectations of improved valuations and a steeper yield curve in 2025.
Two new directors joined in 2024, enhancing board expertise in financial services, capital markets, and audit.
Voting matters and shareholder proposals
Stockholders will vote on electing seven directors, an advisory say-on-pay vote, and ratification of PwC as independent auditor for 2025.
The board recommends voting FOR all proposals.
Only holders of record as of March 14, 2025, are eligible to vote.
Board of directors and corporate governance
Seven of nine current directors are independent; all board committees are fully independent.
Board refreshment includes age limits and annual effectiveness reviews with external advisors.
Board diversity is emphasized, with 4 of 7 nominees considered diverse and 6 of 7 independent.
The board separates CEO and Chair roles and maintains a code of conduct and insider trading policy.
Board committees include Audit, Compensation, and Nomination & Corporate Governance, all with independent members.
Latest events from Invesco Mortgage Capital
- Director elections, executive pay, and auditor ratification up for vote at the 2026 annual meeting.IVR
Proxy filing20 Mar 2026 - Board refreshment, strong returns, and robust governance highlight this year's proxy agenda.IVR
Proxy filing20 Mar 2026 - Book value per share rose 3.7% to $8.72, with an 8.0% economic return and higher dividend.IVR
Q4 20252 Feb 2026 - Book value per share fell 8% in Q2, but distributable earnings and dividend remained stable.IVR
Q2 20241 Feb 2026 - Q3 2024 saw a return to profitability, higher book value, and a 5.4% economic return.IVR
Q3 202416 Jan 2026 - Book value dropped 4.8% in Q4, with net loss and improved capital structure amid volatility.IVR
Q4 202423 Dec 2025 - Shelf registration allows up to $650M in securities for REIT investment and capital needs.IVR
Registration Filing16 Dec 2025 - Director elections, executive pay, and auditor ratification up for vote at May 2025 meeting.IVR
Proxy Filing1 Dec 2025 - Earnings rebounded in Q1 2025, but book value fell as volatility and risks persisted.IVR
Q1 202525 Nov 2025